Market Overview

UPDATE: Topeka Capital Markets Upgrades Monsanto to Buy on Improved Risk Profile

Share:
Related MON
Watch These After-Hours Movers On Wednesday Morning
Monsanto Q3 Earnings Beat Estimates
Tracking Kahn Brothers Portfolio - Q2 2015 Update (Seeking Alpha)

Topeka Capital Markets raised its rating on Monsanto (NYSE: MON) from Hold to Buy with a $107 price target.

Topeka Capital Markets said, "When initiating coverage with a Hold rating in Sept., we acknowledged MON's positive commercial momentum, and anticipated positive Ag fundamentals – particularly in corn –would remain a favorable tailwind for the Company. These aspects of the MON story remain intact. Our cautiousness was based primarily on perceptions regarding questions about the diminishing effectiveness of certain biotech traits, which could ultimately undermine MON's valuation, along with perceived uncertainty regarding the impending expiration of MON's RR patent in 2014. We now believe these potential issues could be less acute, if not benign, at least in the relatively near-term."

Monsanto closed at $88.42 on Monday.

Latest Ratings for MON

DateFirmActionFromTo
Jun 2015BarclaysMaintainsEqual-weight
Jun 2015Atlantic EquitiesUpgradesUnderweightNeutral
May 2015Wells FargoDowngradesOutperformMarket Perform

View More Analyst Ratings for MON
View the Latest Analyst Ratings

Posted-In: Topeka Capital MarketsAnalyst Color Upgrades Intraday Update Analyst Ratings

 

Related Articles (MON)

Get Benzinga's Newsletters